Amwell will announce Q3 2025 results on Nov. 4, followed by a conference call and investor conference participation.
Quiver AI Summary
Amwell Inc. will announce its third quarter 2025 operating results after market hours on November 4, followed by a live conference call and webcast at 5 p.m. ET for discussing the results and providing a business update. The earnings report and webcast can be accessed on the company’s website, with a replay available for 90 days. Additionally, CFO Mark Hirschhorn is scheduled to participate in investor conferences, including one-on-one meetings at the UBS Global Healthcare Conference on November 11 and a panel discussion at the BTIG Digital Health Forum on November 24. Amwell offers a comprehensive software platform aimed at improving access to healthcare, serving a large number of patients and healthcare organizations globally for nearly two decades.
Potential Positives
- Amwell will report its third quarter 2025 operating results on November 4, with a subsequent live conference call, showcasing the company's commitment to transparency and investor communication.
- Company executives are actively participating in upcoming investor conferences, which may enhance investor relations and visibility in the healthcare sector.
- The Amwell platform is highlighted as a comprehensive solution that has been proven to operate at scale, demonstrating its effectiveness in providing care for millions of patients.
- Amwell's long history of servicing large healthcare organizations underscores its reputation and reliability in the healthcare technology field.
Potential Negatives
- Timing of the earnings report announcement is close to the upcoming investor conferences, which may raise concerns about transparency if key financial data is not disclosed beforehand.
- There is no mention of expected performance or guidance for the upcoming quarter, which could lead to investor uncertainty.
- Potential reliance on external channels for earnings information could indicate a lack of confidence in current business performance.
FAQ
When will Amwell report its third quarter 2025 results?
Amwell will report its third quarter 2025 results after trading hours on Tuesday, Nov. 4.
How can I access the Amwell earnings webcast?
The earnings webcast can be accessed via the Investors section of the Amwell website.
What time is the Amwell earnings call scheduled?
The Amwell earnings call is scheduled for 5 p.m. ET on Nov. 4.
Who will represent Amwell at upcoming investor conferences?
Mark Hirschhorn, CFO and COO, will represent Amwell at the UBS Global Healthcare Conference and BTIG Digital Health Forum.
What does the Amwell platform provide for healthcare?
The Amwell platform offers a comprehensive, technology-enabled care solution for payers and health systems to enhance patient access and outcomes.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$AMWL Insider Trading Activity
$AMWL insiders have traded $AMWL stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $AMWL stock by insiders over the last 6 months:
- DMITRY ZAMANSKY (Chief Product & Tech. Officer) sold 25,605 shares for an estimated $173,407
- PHYLLIS GOTLIB (President, International) has made 0 purchases and 5 sales selling 19,779 shares for an estimated $139,260.
- DEBORAH C JACKSON has made 0 purchases and 3 sales selling 13,593 shares for an estimated $92,686.
- PAUL FRANCIS MCNEICE (Chief Accounting Officer) has made 0 purchases and 5 sales selling 897 shares for an estimated $6,454.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AMWL Hedge Fund Activity
We have seen 0 institutional investors add shares of $AMWL stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KIKER WEALTH MANAGEMENT, LLC removed 8 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $71
- CREATIVE CAPITAL MANAGEMENT INVESTMENTS LLC removed 4 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $24
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AMWL Analyst Ratings
Wall Street analysts have issued reports on $AMWL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 08/07/2025
To track analyst ratings and price targets for $AMWL, check out Quiver Quantitative's $AMWL forecast page.
$AMWL Price Targets
Multiple analysts have issued price targets for $AMWL recently. We have seen 4 analysts offer price targets for $AMWL in the last 6 months, with a median target of $8.5.
Here are some recent targets:
- Stan Berenshteyn from Wells Fargo set a target price of $12.0 on 08/07/2025
- Jessica Tassan from Piper Sandler set a target price of $8.0 on 05/23/2025
- Kevin Caliendo from UBS set a target price of $9.0 on 05/08/2025
- David Grossman from Stifel set a target price of $8.0 on 05/02/2025
Full Release
BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report third quarter 2025 operating results after stock market trading hours on Tuesday, Nov. 4.
Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.
The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.
In addition, company executives will attend these upcoming investor conferences:
- Mark Hirschhorn, CFO and COO, will participate in one-on-one meetings at the UBS Global Healthcare Conference on Nov. 11 in Palm Beach Gardens. Fl.
- Mark Hirschhorn, will participate in a panel discussion titled “Transforming a Sick-Care System into a Health-Care System,” taking place virtually at 8:00 a.m. ET at the BTIG Digital Health Forum on Nov. 24.
An audio webcast of the fireside chat will be available at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or
LinkedIn
.
Investors:
Asher Dewhurst
[email protected]
Media:
[email protected]
